e-learning
resources
London 2016
Sunday, 04.09.2016
Lung cancer and immune cells: friends or foes?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD-like inflammation drives the progression of K-ras induced early cancerous lesions
Christopher Jungnickel (Homburg, Germany), Christopher Jungnickel, Philipp Schnabel, Rainer Bohle, Robert Bals, Christoph Beisswenger
Source:
International Congress 2016 – Lung cancer and immune cells: friends or foes?
Session:
Lung cancer and immune cells: friends or foes?
Session type:
Poster Discussion
Number:
520
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Christopher Jungnickel (Homburg, Germany), Christopher Jungnickel, Philipp Schnabel, Rainer Bohle, Robert Bals, Christoph Beisswenger. COPD-like inflammation drives the progression of K-ras induced early cancerous lesions. Eur Respir J 2016; 48: Suppl. 60, 520
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Promotion of lung cancer progression by COPD-like chronic inflammation in a mouse model
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
RBM5 regulates EGFR involving in cancerous transformation of cigarette smoke-induced BEAS-2B cells
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome in resected non-small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
IL-17C promotes tumor-associated inflammation and lung tumor growth
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016
MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
MET genetic lesions in NSCLC are functional markers of early hematogenous spreading and radioresistance
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Deciphering the link between COPD and lung cancer: Cigarette smoke-induced immunosuppression at the crossroads between cancer immune surveillance and escape
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Chemokines CXCL12 and CCL21 may contribute to the development of lung cancer in COPD patients
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Correlation between EGFR mutations and emphysematous changes in heavy smokers with lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Lung cancer: immunopathology
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48
Year: 2001
Prevalence of molecular changes in resected pulmonary adenocarcinomas
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Prevalence of preinvasive bronchial lesions in patients with lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
LATE-BREAKING ABSTRACT: The role of eosinophils in Kras-G12D induced lung tumor initiation and progression
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
A requirement for IKKa in lung adenocarcinoma
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept